智通财经APP从医渡科技获悉,医渡科技(02158)已将DeepSeek人工智能模型整合至公司自主研发的"AI医疗大脑"YiduCore,将进一步推动AI技术在医疗健康产业的规模化应用与创新实践。
YiduCore对DeepSeek的接入,提升了深度挖掘数据价值的能力,使得生成更加精准的疾病洞察,有效打通数据与场景之间的壁垒,为研究、诊疗及公共健康三大类场景提供强有力的智能化支持,同时助力医疗服务降低成本,提升医疗行业供给端的效率,提供更加精准的决策能力。截至2024年9月30日,YiduCore已经累计处理和分析了超55亿份经授权的医疗记录,医院网络覆盖超过2800家,疾病知识图谱已基本涵盖所有已知疾病。
根据中国国际广播电台经济之声联合赛迪顾问股份有限公司发布的《2024年人工智能大模型行业调查研究报告》,医渡科技在市场地位和发展能力两个关键指标上均表现卓越,稳居领导者象限第一。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.